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Left subclavian artery revascularization: Society for
Vascular Surgery® Practice Guidelines
Jon S. Matsumura, MD, and Adnan Z. Rizvi, MD, Madison, Wisc; and Minneapolis, MinnThe use of thoracic stent grafts to manage patients with
various aortic pathologies is a rapidly expanding area in the
field of vascular surgery. It has supplanted traditional open
surgery in the treatment of many specific aortic diseases,
including descending thoracic aneurysms, acute compli-
cated dissection, traumatic transection, and penetrating
ulcers. Because of the need for an adequate proximal seal
zone and limitations of current technology of stent grafts,
the left subclavian artery (LSA) may need to be covered in
26% to 40% of patients undergoing thoracic endovascular
aortic repair (TEVAR).1,2
In the first United States regulatory trial,3 all patients
were required to undergo prophylactic LSA revasculariza-
tion before TEVAR if the LSA was covered, but this prac-
tice has not become predominant in clinical practice. There
is great variability amongst surgeons and interventionalists
about which patient undergoes LSA revascularization be-
fore TEVAR. Some surgeons perform routine LSA revas-
cularization, whereas others are selective, such as in cases of
a left vertebral artery ending at the posterior inferior cere-
bellar artery, a prior left internal mammary-to-coronary
artery bypass, or an absent distal right vertebral artery.
Lastly, some surgeons only perform LSA revascularization
if symptoms of left arm ischemia or subclavian steal syn-
drome occur after TEVAR.1,4,5 Unfortunately, most of the
data about LSA coverage during TEVAR and the morbidity
and mortality associated with this come from single insti-
tutional series or registries, thus the current management of
the LSA when coverage is necessary is not uniform.
The Society for Vascular Surgery® (SVS) recently formed
a Committee on Aortic Disease to formulate clinical prac-
tice guidelines to aid physicians and patients regarding LSA
revascularization during TEVAR. A third-party, the Knowl-
edge and Encounter Research Unit, Mayo Clinic, Rochester,
performed a comprehensive literature review and formu-
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doi:10.1016/j.jvs.2010.07.003lated a systematic review and meta-analysis relating the
effect of LSA coverage on the morbidity and mortality of
patients undergoing TEVAR.6 The SVS used this review
and the consensus of the committee to develop three
recommendations regarding LSA revascularization in rela-
tionship to TEVAR.7 This article reviews the potential
complications associated with LSA coverage and summa-
rizes the SVS Practice Guidelines in the management of the
LSA during TEVAR.
COMPLICATIONS ASSOCIATED WITH LSA
COVERAGE DURING TEVAR
The LSA provides blood flow to the left arm but also
provides important additional perfusion pathways to the
brain by the left vertebral artery and spinal cord through the
left vertebral artery, internal thoracic artery, subscapular
artery, and lateral thoracic artery. These LSA collaterals are
important during TEVAR, and their disruption can cause
significant morbidity and death. Complications associated
with coverage of the LSA during TEVAR include stroke,
spinal cord ischemia, and left upper extremity ischemia.
Stroke. The incidence of stroke after TEVAR ranges
from 3.8% to 6.3%.8 The etiology is multifactorial and is
likely related to patient and procedural variables, including:
1. patient age and underlying cerebral vascular disease;
2. periprocedural hypotension or hypertension;
3. etiology of the treated aortic pathology and proximal
extent of the disease;
4. embolization of air or atheromatous debris during de-
vice manipulation or deployment; and
5. coverage of important vessels with the device for disease
involving the arch vessels.
Most anterior circulation strokes are likely embolic,
whereas posterior circulation strokes tend to be ischemic in
origin. Studies have shown that 60% of patients have a
dominant left vertebral artery, with the contralateral verte-
bral either atretic or absent; thus, unknowingly covering
the LSA artery in an individual with this anatomic variant
has risk. Some studies have demonstrated a higher overall
stroke rate (13% vs 2%) and posterior circulation stroke rate
(5.5% vs 1.2%) with intentional coverage of the LSA com-
pared with LSA revascularization.2,5
A recent study by Holt et al9 specifically analyzing their
institution’s results of treating aortic arch aneurysms (prox-
imal landing zone 0, 9; zone 1, 17; zone 2, 52) with a
hybrid approach further enlightens us on the importance of
the LSA. The incidence of stroke was 0% in 35 patients who
underwent LSA artery revascularization compared with
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(P  .046). The combined stroke-paraplegia-death rate
comparing the two cohorts was striking: 0% vs 27.9% (P 
.001). This was not a randomized trial and used historic
controls and may be limited by confounding improvements
that also occurred at St. George’s Vascular Institute, a
high-volume institution. Nevertheless, a thorough preop-
erative understanding of the anatomy of the arch and
cerebral anatomy, routine LSA revascularization, and care-
ful manipulation of wires, catheters, and device during stent
graft deployment are crucial in minimizing the incidence of
stroke during TEVAR.
Spinal cord ischemia. The anterior spinal artery is an
important vessel for supplying blood to the motor horns of the
spinal cord. It receives inflow from branches off the vertebral
artery as well as from intercostal and lumbar arteries off the
thoracoabdominal aorta. As with stroke, the etiology of spinal
cord ischemia after TEVAR is multifactorial. (See the article by
Drs Rizvi and Sullivan for a detailed review of spinal cord
protection.) Potential contributors to spinal cord ischemia
include:
1. periprocedural hypotension;
2. embolization to the intercostal artery;
3. intraspinal hematoma; and
4. lack of adequate perfusion to the anterior spinal artery
after coverage of important collaterals, including the
intercostal, lumbar, middle sacral, hypogastric, or sub-
clavian arteries.
A few recent studies have alluded to the importance of
patency of the LSA in reducing the risk of spinal cord ischemia.
A review of the European Collaborators on Stent-Graft Tech-
Fig 1. Arm ischemia: random-effects meta-analysis. The
confidence intervals (CI), the diamond represents the poo
pooled estimate.niques for Aortic Aneurysm Repair (EUROSTAR) registryfound LSA coverage without revascularization resulted in a
8.4% incidence of spinal cord ischemia or stroke compared
with 0% in patients with LSA revascularization (P .049).1
Left upper extremity ischemia. Upper extremity
ischemia is uncommon after acute occlusion of the LSA for
TEVAR and is generally tolerated, but symptoms can range
from minimal to an acutely ischemic hand. In addition, flow
reversal in the left vertebral artery occurs after covering the
LSA. Most patients are asymptomatic; however, in certain
cases a true steal phenomenon can occur, with resultant
symptoms from vertebrobasilar insufficiency of syncope,
diplopia, or vertigo. A recent series reported upper extrem-
ity ischemia occurred 12% to 20% of the time after LSA
coverage; however, 40% of patients with symptoms
of arm ischemia underwent delayed LSA revasculariza-
tion.10,11 In regards to onset of symptoms, an immediately
threatened arm is exceedingly rare, and presentation of
ischemic symptoms of the arm is often delayed (range, 2
day-26 months) after TEVAR.10,11 The delayed presenta-
tion of upper extremity ischemia or vertebrobasilar insuffi-
ciency means revascularization for these risks can typically
be addressed on a less urgent basis.
EVIDENCE
The systematic review and meta-analysis from the
Knowledge and Encounter Research Unit, Mayo Clinic,
Rochester, showed that coverage of the LSA without revas-
cularization was associated with a trend toward an increased
risk of paraplegia (odds ratio [OR], 2.69; 95% confidence
interval [CI], 0.75-9.68) and anterior circulation stroke
(OR, 2.58; 95% CI, 0.82-8.09), and a much higher risk for
arm ischemia (OR, 47.7; 95% CI, 9.9-229.3) and vertebro-
es are odds ratios of individual studies, the lines are 95%
ffect, and the width of the diamond is the 95% CI of thesquar
led ebasilar ischemia (OR, 10.8; 95% CI, 3.17-36.7) compared
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ization6 (Figs 1 to 4). A literature review of patients who
underwent LSA revascularization showed the overall inci-
dence of phrenic nerve injury was 4.4% (95% CI, 1.6%-
12.20%). Coverage of the LSA without revascularization
was not associated with an increased risk of death, myocar-
dial infarction, or transient ischemic attack.
RECOMMENDATIONS OF THE SVS
The Committee reviewed the available data and used
the Grading of Recommendation Assessment, Develop-
ment and Evaluation (GRADE) method,12 as well as group
consensus, to determine its recommendations (Table). The
Fig 2. Vertebrobasilar ischemia: random-effects meta-a
lines are 95% confidence intervals (CI), the diamond rep
95% CI of the pooled estimate.
Fig 3. Spinal cord ischemia: random-effects meta-analy
are 95% confidence intervals (CI), the diamond represen
CI of the pooled estimate.SVS was aware of the limitations of the systematic review,acknowledging that the studies reviewed were observa-
tional in nature, the patients in the studies were heteroge-
nous in diagnosis, morbidity, and aortic pathology, the data
of interest (stroke, death, spinal cord ischemia) occurred
infrequently, and reported data were not consistent or
uniform. Despite the low-quality evidence on which to base
their recommendations, the Committee understood that
neurologic complications (stroke and paraplegia) associ-
ated with TEVAR are clinically important, and a high value
was placed on avoiding these complications when the
guidelines were developed. The SVS guideline recommen-
dations, based on a systematic review and meta-analysis of
the literature, are as follows:
Recommendation 1: For elective TEVAR where cov-
is. The squares are odds ratios of individual studies, the
ts the pooled effect, and the width of the diamond is the
he squares are odds ratios of individual studies, the lines
pooled effect, and the width of the diamond is the 95%nalys
resensis. T
ts theerage of the LSA is necessary for adequate stent graft seal,
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(Very low-quality evidence, GRADE 2, level C).
Recommendation 2: For patients where the anatomy
to be treated comprises perfusion to vital organs, the SVS
strongly recommends routine preoperative LSA revascular-
ization. (Very low-quality evidence, GRADE 1, level C).
Consensus-ranked examples of these circumstances in-
clude:
● Presence of a patent left internal mammary to coronary
artery bypass graft
● Termination of the left vertebral artery into the poste-
rior inferior cerebellar artery
● Absent, atretic, or occluded right vertebral artery
● Patent left arm arteriovenous shunt for dialysis
● Prior infrarenal aortic operation with previously li-
gated lumbar and middle sacral arteries
● Planned extensive (20-cm) coverage of the descend-
ing thoracic aorta
Fig 4. Anterior circulation stroke: random-effects meta
lines are 95% confidence intervals (CI), the diamond rep
95% CI of the pooled estimate.
Table. Recommendations according to the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) system12
The GRADE system categorizes recommendations as
● strong (GRADE 1) denoted by the phrase “we
recommend,” or
● weak (GRADE 2) denoted by the phrase “we suggest.”
The quality of evidence is graded as
● high-quality (level A), typically derived from well conducted
randomized trials,
● moderate-quality (level B), typically derived from less
rigorous or inconsistent randomized trials,
● low-quality or very-low quality (level C), derived from
observational studies, case series, and unsystematic
observations or expert opinion.● Hypogastric artery occlusion● Presence of early aneurysmal disease where future ther-
apy involving the distal thoracic aorta may be necessary
Recommendation 3: For patients with acute thoracic
emergencies where TEVAR is required more urgently and
coverage of the LSA will be necessary, the SVS suggests that
revascularization should be individualized and addressed
according to the patient’s anatomy, urgency of the proce-
dure, and availability of surgical expertise for LSA revascu-
larization (GRADE 2, level C).
LSA REVASCULARIZATION
In the past, LSA revascularization with a carotid-
subclavian bypass or transposition was performed typically for
atherosclerotic occlusive disease. With the advent of TEVAR,
this operation has become much more common for sur-
geons. Although not completely benign, LSA revascular-
ization, especially in the setting of TEVAR, has a very low
associated morbidity and mortality. The recent systematic
review reported the overall incidence of phrenic nerve
injury was low, at 4.4%.6 The University of Pennsylvania
group recently reviewed their experience of LSA revascu-
larization in patients undergoing TEVAR. In their series,
42 of 70 patients (60%) required LSA revascularization (5
transpositions, 37 bypasses), and the only complication was
a patient (2.4%) with phrenic nerve palsy.
Similarly, Peterson et al5 reported their experience of
23 patients who underwent LSA revascularization, com-
prising 21 transpositions and 2 bypasses, before TEVAR.
Vocal paralysis developed in two patients (8.7%) related to
the operation, of which one resolved spontaneously.
A systematic review of the literature by Cina et al13 eval-
uated carotid-subclavian bypasses or transpositions reported
between 1996 and 2000. The reported patency at a mean of
sis. The squares are odds ratios of individual studies, the
ts the pooled effect, and the width of the diamond is the-analy
resen59 months was superior with subclavian-carotid transposition
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is that most of the operations in this systematic review were for
occlusive disease rather than for LSA revascularization before
TEVAR. A more in depth discussion of debranching of all
three arch vessels is covered in the article by Drs Vallabhaneni
and Sanchez.
Finally, numerous case reports have been published
on various techniques for percutaneous management of
the arch vessels when planned coverage is anticipated
(See the article by Drs Longo and Pipinos). Although
premade fenestrated stent grafts have been well de-
scribed, they have limited availability to practicing clini-
cians14 (See the article by Drs Greenberg and Qureshi).
Additional techniques to percutaneously manage planned
LSA coverage with stent grafts include the “double-barrel”
or “chimney” technique. Typically with this technique, a
covered stent is positioned from a retrograde left brachial
approach and deployed in a “kissing” fashion, traversing
the origin of the LSA when the thoracic stent graft is
deployed. The thoracic stent graft forms a seal around the
LSA stent, maintaining antegrade flow. In the short-term,
the reported cases demonstrate 100% patency and no type I
endoleak.15,16
Equally novel is in situ fenestration for TEVAR involv-
ing the arch vessels, which is detailed in the article by Drs
Longo and Pipinos. Various techniques have been de-
scribed using a retrograde approach to create an in situ
fenestration in the stent graft fabric. The final step is placing
a covered stent to bridge the hole in the stent graft to the
target vessel being treated.17-19 Although in their infancy,
and without any data on durability and effect on graft
structural integrity, these may be novel endovascular tech-
niques to maintain antegrade flow in the arch vessels and
obviate the need for surgical debranching procedures.
CONCLUSIONS
The Society for Vascular Surgery® Practice Guidelines
“suggest” routine preoperative revascularization when the
left subclavian artery is covered during TEVAR and provide
a stronger “recommend” for routine revascularization in
circumstances where collateral perfusion may be compro-
mised. Exceptions include emergent TEVAR and when
other circumstances preclude preoperative LSA revascular-
ization. These guidelines are based on the analysis of 51
eligible studies by the Mayo Clinic Knowledge and En-
counter Research Unit, which found risk increases of 48-
fold for arm ischemia, 11-fold for vertebrobasilar ischemia,
2.7-fold for spinal cord ischemia, and 2.6-fold for anterior
circulation stroke when the LSA was covered without re-
vascularization during TEVAR compared with revascular-
ization. However, the latter two risk increases are not
statistically significant, and the quality of evidence is very
low. Taken together with other emerging data, under-
standing the detailed anatomy, and considering the devas-
tating nature of neurologic complications, it seems prudent
to preserve antegrade flow in the left subclavian artery.AUTHOR CONTRIBUTIONS
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